Bill Commons

KY HB 646

died on adjournment

AN ACT relating to the use of pharmaceuticals to intentionally terminate life.

Kentucky · 2026 Regular Session · lower

Follow this bill’s action updates (Atom)

Subscribe in a feed reader. The feed covers recorded actions from the last 30 days; Bill Commons may record an action after it happened at the legislature.

Quick answers

Did KY HB 646 pass?

No. KY HB 646 died when the 2026 Regular Session adjourned without final action on it. Bills that die this way are sometimes reintroduced in a later session. Latest recorded action (2026-02-23): to Judiciary (H)

What is KY HB 646 about?

Amend KRS 218A.100 to place an abortion-inducing drug in Schedule IV; amend KRS 218A.1413 to include an abortion-inducing drug in the offense of trafficking in a controlled substance in the second degree; amend KRS 218A.1415 to include an abortion-inducing drug in the offense of possession of a controlled substance in the first degree, except when in the possession of a pregnant woman for her own personal use; create a new section of KRS Chapter 218A to establish the offense of importing an abortion-inducing drug amend KRS 216.302 to include providing any drug, medication, or other substance as a means of assisting another person to commit or attempt to commit suicide; increase the penalty from a Class D felony to a Class B felony when the act is done knowingly by force or duress and from a Class C to a Class B felony when a person knowingly or intentionally provides the physical means or participates in a physical act by which another person commits or attempts suicide; create a new section of KRS 216.300 to 216.308 to establish the offense of medically assisted aid in dying as a Class B felony; amend KRS 216.308 to provide for the revocation of a license upon a criminal conviction or plea of guilty of assisted suicide or medically assisted aid in dying; create a new section of KRS Chapter 411 to provide a civil cause of action for any person who sustains damages resulting from receiving an abortion-inducing drug; create a new section of KRS Chapter 216B to require the distribution of specified information to any patient who a physician or other healthcare provider believes is experiencing a complication as a result of taking an abortion-inducing drug; require the Cabinet for Health and Family Services to make specified information available on its website.

Who sponsors KY HB 646?

T. Smith, F. Rabourn, M. Proctor and 18 others are the primary sponsors of KY HB 646.

Description

Amend KRS 218A.100 to place an abortion-inducing drug in Schedule IV; amend KRS 218A.1413 to include an abortion-inducing drug in the offense of trafficking in a controlled substance in the second degree; amend KRS 218A.1415 to include an abortion-inducing drug in the offense of possession of a controlled substance in the first degree, except when in the possession of a pregnant woman for her own personal use; create a new section of KRS Chapter 218A to establish the offense of importing an abortion-inducing drug amend KRS 216.302 to include providing any drug, medication, or other substance as a means of assisting another person to commit or attempt to commit suicide; increase the penalty from a Class D felony to a Class B felony when the act is done knowingly by force or duress and from a Class C to a Class B felony when a person knowingly or intentionally provides the physical means or participates in a physical act by which another person commits or attempts suicide; create a new section of KRS 216.300 to 216.308 to establish the offense of medically assisted aid in dying as a Class B felony; amend KRS 216.308 to provide for the revocation of a license upon a criminal conviction or plea of guilty of assisted suicide or medically assisted aid in dying; create a new section of KRS Chapter 411 to provide a civil cause of action for any person who sustains damages resulting from receiving an abortion-inducing drug; create a new section of KRS Chapter 216B to require the distribution of specified information to any patient who a physician or other healthcare provider believes is experiencing a complication as a result of taking an abortion-inducing drug; require the Cabinet for Health and Family Services to make specified information available on its website.

Introduced
2026-02-13
Latest action
2026-02-23 — to Judiciary (H)
Bill type
bill
Last updated
—

Subjects

Sponsors

  • T. Smithprimary
  • F. Rabournprimary
  • M. Proctorprimary
  • J. Nemesprimary
  • K. Moserprimary
  • C. Massaroniprimary
  • S. Maddoxprimary
  • M. Lockettprimary
  • K. Kingprimary
  • T. Huffprimary
  • J. Hodgsonprimary
  • D. Haleprimary
  • D. Gordonprimary
  • D. Fisterprimary
  • R. Dotsonprimary
  • S. Doanprimary
  • J. Deckerprimary
  • K. Bantaprimary
  • S. Bakerprimary
  • T. Robertsprimary
  • N. Tateprimary

Committees

Not provided by source.

Action timeline

Newest first

  1. 2026-02-23

    to Judiciary (H)

    referral-committee

  2. 2026-02-13

    to Committee on Committees (H)

    referral-committee

  3. 2026-02-13

    introduced in House

    introduction

Versions

Documents

Votes

Not provided by source.

Related bills

No related bills recorded for this bill.

Official source

Attribution

Data from openstates_api_sync, retrieved 2026-08-21T21:05:44.493618Z

Inspect retained evidence for changes recorded after evidence tracking began:

Session-wide evidence can include changes to other bills:

Use this data

Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=KY&identifier=HB 646. See the API docs or the MCP server for AI assistants.

Known limitations

  • Sponsor party and chamber affiliation are not yet captured by this API.
  • Committee referrals are not yet captured.

See the methodology page for data sources and limitations.